Preclinical and Clinical R&D - Cardiovascular & Metabolic

Pharmahungary is an innovative preclinical (nonclinical) and clinical R&D company providing contract research with strong scientific support and offering early-stage novel technologies:

  • innovative and cost-effective preclinical (nonclinical) CRO focusing on cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) and metabolic diseases (diabetes, dyslipidemia, hyperlipidemia, atherosclerosis, obesity, uremia, etc) including large animal models with in vivo imaging
  • clinical R&D services: focusing on Medical Devices, Investigator Initiated Trials (IITs). Uniquely positioned from early stage of development to post market of medical devices and combination products clinical trial services.

  • Pharmahungary manages internal preclinical (nonclinical) R&D projects to develop new technologies in the fields of diagnosis and therapy of cardiovascular diseases. Some projects are open for out-licensing, co-development, and investment.

Our innovative R&D solutions (InnoRD™) reduce the cost and the duration of your preclinical (nonclinical) and clinical project.

To reduce costs and speed up your drug development projects, the best way is to outsource your preclinical (nonclinical) and clinical studies to a cost effective preclinical (nonclinical) & clinical CRO.

Pharmahungary Group is more than a CRO: your creative preclinical (nonclinical) and clinical research team.